|
Volumn 65, Issue 6, 2008, Pages
|
Diabetes specialists keep ACCORD data in perspective
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN A1C;
ANTIDIABETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
METFORMIN;
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
HEALTH CARE;
HEALTH CARE PERSONNEL;
HEALTH SURVEY;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
OBESITY;
PHARMACIST;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
CHEMICALLY INDUCED DISORDER;
DIABETIC ANGIOPATHY;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HEALTH CARE ORGANIZATION;
IMPAIRED GLUCOSE TOLERANCE;
MORTALITY;
UNITED STATES;
BLOOD GLUCOSE;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
METFORMIN;
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.);
PRACTICE GUIDELINES AS TOPIC;
PREDIABETIC STATE;
UNITED STATES;
|
EID: 41049118136
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news080021 Document Type: Note |
Times cited : (1)
|
References (0)
|